See more : Norcod AS (NCOD.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Alexander’s, Inc. (ALX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alexander’s, Inc., a leading company in the REIT – Retail industry within the Real Estate sector.
You may be interested
- Alstom SA (ALSMY) Income Statement Analysis – Financial Results
- Basilea Pharmaceutica AG (BPMUF) Income Statement Analysis – Financial Results
- Ceapro Inc. (CRPOF) Income Statement Analysis – Financial Results
- Torr Metals Inc. (TMET.V) Income Statement Analysis – Financial Results
- Goal Acquisitions Corp. (PUCKW) Income Statement Analysis – Financial Results
Alexander's, Inc. (ALX)
About Alexander's, Inc.
Alexander's, Inc. is a real estate investment trust which has seven properties in the greater New York City metropolitan area.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 224.96M | 205.81M | 206.15M | 199.14M | 226.35M | 232.83M | 230.57M | 226.94M | 207.92M | 200.81M | 196.46M | 191.31M | 204.27M | 183.83M | 168.38M | 163.85M | 170.01M | 179.58M | 139.18M | 110.15M | 75.45M | 55.48M | 69.14M | 43.67M | 47.80M | 22.50M | 21.60M | 25.20M | 2.50M | 13.20M | 4.90M | 2.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 101.21M | 90.45M | 21.14M | 88.40M | 89.74M | 93.78M | 85.13M | 82.23M | 76.22M | 69.90M | 64.68M | 61.76M | 84.94M | 78.65M | 73.34M | 77.11M | 70.50M | 71.98M | 64.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 123.75M | 115.37M | 185.01M | 110.74M | 136.61M | 139.05M | 145.45M | 144.70M | 131.70M | 130.92M | 131.78M | 129.56M | 119.33M | 105.18M | 95.04M | 86.74M | 99.51M | 107.60M | 74.30M | 110.15M | 75.45M | 55.48M | 69.14M | 43.67M | 47.80M | 22.50M | 21.60M | 25.20M | 2.50M | 13.20M | 4.90M | 2.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 55.01% | 56.05% | 89.75% | 55.61% | 60.35% | 59.72% | 63.08% | 63.76% | 63.34% | 65.19% | 67.08% | 67.72% | 58.42% | 57.21% | 56.44% | 52.94% | 58.53% | 59.92% | 53.39% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.28 | 0.63 | 0.21 | 0.39 | 0.36 | 0.35 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.34M | 6.11M | 5.92M | 6.31M | 5.77M | 5.34M | 5.25M | 5.44M | 5.41M | 5.03M | 5.28M | 5.16M | 84.94M | 86.44M | 101.59M | 91.68M | -38.34M | 154.84M | 32.39M | 81.29M | 48.92M | 3.96M | 3.86M | 3.89M | 3.70M | 4.10M | 3.90M | 4.40M | 5.10M | 3.60M | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.34M | 6.11M | 5.92M | 6.31M | 5.77M | 5.34M | 5.25M | 5.44M | 5.41M | 5.03M | 5.28M | 5.16M | 84.94M | 86.44M | 101.59M | 91.68M | -38.34M | 154.84M | 32.39M | 81.29M | 48.92M | 3.96M | 3.86M | 3.89M | 3.70M | 4.10M | 3.90M | 4.40M | 5.10M | 3.60M | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 120.24M | 124.03M | 120.76M | 121.09M | 126.86M | 120.05M | 116.04M | 107.30M | 99.09M | 93.66M | 90.57M | 3.06M | -3.44M | -29.59M | -4.68M | 93.34M | 94.16M | 84.61M | -184.58M | -128.43M | -12.97M | -23.14M | -20.93M | -28.40M | -17.60M | -4.60M | 9.00M | -3.50M | -9.50M | -4.10M | -134.90M | -4.20M | -3.90M | 20.90M | -4.30M | 1.30M | 2.70M |
| Operating Expenses | 6.34M | 126.35M | 129.95M | 127.07M | 126.86M | 132.20M | 125.30M | 121.48M | 112.71M | 104.13M | 98.94M | 95.73M | 88.00M | 83.00M | 72.00M | 87.00M | 55.00M | 249.00M | 117.00M | -103.30M | -79.51M | -9.01M | -19.28M | -17.04M | -24.70M | -13.50M | -700.00K | 13.40M | 1.60M | -5.90M | -2.90M | -134.90M | -4.20M | -3.90M | 20.90M | -4.30M | 1.30M | 2.70M |
| Cost & Expenses | 107.55M | 126.35M | 129.95M | 127.07M | 126.86M | 132.20M | 125.30M | 121.48M | 112.71M | 104.13M | 98.94M | 95.73M | 88.00M | 83.00M | 72.00M | 87.00M | 55.00M | 249.00M | 117.00M | -103.30M | -79.51M | -9.01M | -19.28M | -17.04M | -24.70M | -13.50M | -700.00K | 13.40M | 1.60M | -5.90M | -2.90M | -134.90M | -4.20M | -3.90M | 20.90M | -4.30M | 1.30M | 2.70M |
| Interest Income | 22.25M | 6.77M | 639.00K | 2.67M | 8.24M | 12.55M | 6.72M | 3.31M | 5.95M | 2.43M | 1.53M | 177.00K | 2.67M | 851.00K | 2.85M | 15.22M | 27.35M | 28.26M | 14.77M | 1.57M | 1.98M | 2.18M | 3.24M | 1.12M | 1.00M | 1.00M | 700.00K | 2.90M | 1.70M | 4.80M | 700.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 58.30M | 28.60M | 19.69M | 24.20M | 38.90M | 44.53M | 31.47M | 22.24M | 24.24M | 32.07M | 44.54M | 45.65M | 52.66M | 58.37M | 57.99M | 62.47M | 65.32M | 71.98M | 62.68M | 40.32M | 13.69M | 22.89M | 22.47M | 21.42M | 17.60M | 15.10M | 13.40M | 13.90M | 13.20M | 3.30M | 900.00K | 0.00 | -4.20M | -3.90M | 20.90M | -4.30M | 1.30M | 2.70M |
| Depreciation & Amortization | 32.90M | 126.35M | 126.47M | 135.67M | 108.54M | 116.23M | 95.00M | 92.59M | 33.67M | 31.92M | 31.40M | 36.36M | 37.09M | 34.85M | 30.45M | 26.72M | 24.99M | 24.46M | 22.84M | 18.82M | 11.31M | 8.97M | 7.97M | 8.05M | 7.50M | 5.70M | 4.50M | 4.10M | 4.70M | 2.30M | 800.00K | 5.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 117.41M | 117.69M | 111.43M | 109.86M | 144.25M | 139.67M | 150.66M | 139.27M | 126.29M | 125.89M | 126.50M | 87.10M | 170.69M | 158.03M | 184.44M | 166.42M | 0.00 | 3.95M | 167.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.80M | 0.00 | 2.80M | 0.00 | -4.20M | -3.90M | 20.90M | -4.30M | 1.30M | 2.70M |
| EBITDA Ratio | 52.19% | 57.18% | 54.05% | 55.17% | 63.73% | 65.14% | 65.34% | 63.96% | 64.85% | 65.26% | 66.39% | 69.06% | 83.56% | 85.96% | 109.54% | 101.57% | 120.38% | 18.23% | 120.53% | 23.30% | 9.62% | 99.92% | 83.64% | 79.40% | 64.02% | 65.33% | 117.59% | 169.44% | 352.00% | 72.73% | 57.14% | -5,763.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 51.62M | 86.23M | 76.84M | 74.74M | 107.73M | 100.62M | 105.27M | 105.46M | 95.21M | 96.69M | 97.52M | 95.58M | 133.60M | 123.18M | 154.00M | 139.70M | 179.66M | 8.27M | 144.92M | 6.85M | -4.05M | 46.47M | 49.86M | 26.62M | 23.10M | 9.00M | 20.90M | 38.60M | 4.10M | 7.30M | 2.00M | -132.70M | -4.20M | -3.90M | 20.90M | -4.30M | 1.30M | 2.70M |
| Operating Income Ratio | 22.94% | 41.90% | 37.27% | 37.53% | 47.60% | 43.22% | 45.66% | 46.47% | 45.79% | 48.15% | 49.64% | 49.96% | 65.41% | 67.01% | 91.46% | 85.27% | 105.68% | 4.61% | 104.13% | 6.22% | -5.37% | 83.76% | 72.11% | 60.97% | 48.33% | 40.00% | 96.76% | 153.17% | 164.00% | 55.30% | 40.82% | -6,031.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 50.80M | -21.83M | 21.45M | -21.54M | -70.77M | -77.06M | 0.00 | -18.94M | -18.29M | -29.63M | -43.01M | -45.48M | -49.99M | -58.76M | -55.15M | -47.26M | -39.14M | -36.39M | -163.61M | -66.43M | -25.00M | -31.86M | -30.44M | -29.47M | -25.10M | -20.80M | -17.90M | -18.00M | -13.20M | -5.60M | -900.00K | 118.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 102.41M | 57.63M | 130.58M | 41.94M | 60.08M | 56.65M | 80.51M | 86.53M | 76.92M | 67.06M | 54.50M | 50.11M | 80.94M | 64.80M | 96.01M | 77.23M | 114.34M | -63.71M | 21.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -9.10M | 0.00 | 1.10M | -14.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 45.52% | 28.00% | 63.34% | 21.06% | 26.54% | 24.33% | 34.92% | 38.13% | 36.99% | 33.39% | 27.74% | 26.19% | 39.63% | 35.25% | 57.02% | 47.14% | 67.26% | -35.48% | 15.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -364.00% | 0.00% | 22.45% | -659.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 28.60M | 17.34M | 24.20M | 38.90M | 4.00K | 3.00K | 48.00K | 8.00K | -341.00K | -160.00K | 64.00K | -105.00K | -2.64M | -36.94M | 941.00K | 65.32M | 11.27M | 62.68M | 40.32M | 13.69M | 22.89M | 22.47M | 21.42M | 17.60M | 15.10M | 13.40M | 13.90M | -1.40M | 3.30M | 200.00K | 100.00K | 4.20M | 3.90M | -20.90M | 4.30M | -1.30M | -2.70M |
| Net Income | 102.41M | 29.03M | 132.93M | 17.74M | 21.17M | 32.84M | 80.51M | 86.48M | 76.91M | 67.93M | 56.92M | 674.39M | 79.42M | 66.43M | 132.19M | 76.29M | 114.34M | -74.98M | 82.24M | -33.47M | -17.74M | 23.58M | 27.39M | 5.20M | 5.50M | -6.10M | 7.50M | 24.70M | 2.40M | 4.00M | 900.00K | -132.80M | -4.20M | -3.90M | 20.90M | -4.30M | 1.30M | 2.70M |
| Net Income Ratio | 45.52% | 14.10% | 64.48% | 8.91% | 9.35% | 14.11% | 34.92% | 38.11% | 36.99% | 33.82% | 28.97% | 352.51% | 38.88% | 36.14% | 78.51% | 46.56% | 67.26% | -41.76% | 59.09% | -30.39% | -23.51% | 42.51% | 39.61% | 11.90% | 11.51% | -27.11% | 34.72% | 98.02% | 96.00% | 30.30% | 18.37% | -6,036.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 19.97 | 5.66 | 25.49 | 3.46 | 4.14 | 6.42 | 15.74 | 16.91 | 15.04 | 13.29 | 11.14 | 132.04 | 15.55 | 13.01 | 25.90 | 15.05 | 22.68 | -14.92 | 16.38 | -7.55 | -3.55 | 4.72 | 5.48 | 1.04 | 1.10 | -1.21 | 1.49 | 4.94 | 0.49 | 0.81 | 1.88 | -26.69 | -0.84 | -0.79 | 4.20 | -0.86 | 0.27 | 0.59 |
| EPS Diluted | 19.97 | 5.66 | 25.49 | 3.46 | 4.14 | 6.42 | 15.74 | 16.91 | 15.04 | 13.29 | 11.14 | 132.04 | 15.55 | 13.01 | 25.89 | 14.96 | 22.44 | -14.92 | 16.19 | -7.55 | -3.55 | 4.72 | 5.48 | 1.04 | 1.10 | -1.21 | 1.49 | 4.94 | 0.49 | 0.81 | 1.88 | -26.69 | -0.84 | -0.79 | 4.20 | -0.86 | 0.27 | 0.59 |
| Weighted Avg Shares Out | 5.13M | 5.13M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.11M | 5.11M | 5.11M | 5.11M | 5.11M | 5.11M | 5.11M | 5.10M | 5.07M | 5.04M | 5.03M | 5.02M | 4.43M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.04M | 5.03M | 5.00M | 4.90M | 4.94M | 5.00M | 4.98M | 5.00M | 4.94M | 4.98M | 5.00M | 4.81M | 4.58M |
| Weighted Avg Shares Out (Dil) | 5.13M | 5.13M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.11M | 5.11M | 5.11M | 5.11M | 5.11M | 5.11M | 5.11M | 5.11M | 5.10M | 5.10M | 5.03M | 5.08M | 4.43M | 5.00M | 5.00M | 5.00M | 5.02M | 5.02M | 5.04M | 5.03M | 5.00M | 5.00M | 5.00M | 5.00M | 4.98M | 5.00M | 4.94M | 4.98M | 5.00M | 4.81M | 4.58M |
ALX Resources Corp. Completes Prospecting and Sampling Programs at the Cannon Copper Project, Ontario
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2024) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce that it has completed reconnaissance prospecting and sampling programs (the "Programs") on its 100%-owned Cannon Copper...
3 Highly Ranked REITs to Buy with Rate Cuts Ahead
With the possibility of multiple rate cuts back on the table this year, Real Estate Investment Trusts (REITs) may stand to benefit the most as these equities rely on debt to finance their operations and acquire properties.
Alexander's (ALX) Upgraded to Strong Buy: Here's What You Should Know
Alexander's (ALX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Income Stocks to Buy for August 9th
NREF, DKL and ALX made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 9, 2024.
ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
- Dr. Sandler brings more than 30 years of experience and leadership in oncology and drug development - - Jaume Pons, Ph.D., and Sophia Randolph, M.D.
Alexander's (ALX) Beats Q2 FFO and Revenue Estimates
Alexander's (ALX) came out with quarterly funds from operations (FFO) of $3.31 per share, beating the Zacks Consensus Estimate of $2.57 per share. This compares to FFO of $3.55 per share a year ago.
Alexander's Announces Second Quarter Financial Results
PARAMUS, N.J., Aug. 05, 2024 (GLOBE NEWSWIRE) -- ALEXANDER'S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended June 30, 2024 today and reported:
7 Potential Mousetrap REITs - High, Potentially Unsafe Yields
From a fundamental standpoint, this may be a good time to invest in REITs with high yields. It's crucial to avoid mousetrap REITs with high dividend yields that may be unsustainable, as dividend cuts quickly lead to dramatic losses in...
ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer
SOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced topline data from its Phase...
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
PARAMUS, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $4.50 per share payable on August 30, 2024 to stockholders of record on August 12,...
Source: https://incomestatements.info
Category: Stock Reports